Innate Immune Sensing of Influenza A Virus

Overview

Journal Viruses

Publisher MDPI

Specialty Microbiology

Date 2020 Jul 18

PMID 32674269

Citations 39

Authors

Gaurav Malik

Yan Zhou

Affiliations

Soon will be listed here.

Abstract

Influenza virus infection triggers host innate immune response by stimulating various pattern recognition receptors (PRRs). Activation of these PRRs leads to the activation of a plethora of signaling pathways, resulting in the production of interferon (IFN) and proinflammatory cytokines, followed by the expression of interferon-stimulated genes (ISGs), the recruitment of innate immune cells, or the activation of programmed cell death. All these antiviral approaches collectively restrict viral replication inside the host. However, influenza virus also engages in multiple mechanisms to subvert the innate immune responses. In this review, we discuss the role of PRRs such as Toll-like receptors (TLRs), Retinoic acid-inducible gene I (RIG-I), NOD-, LRR-, pyrin domain-containing protein 3 (NLRP3), and Z-DNA binding protein 1 (ZBP1) in sensing and restricting influenza viral infection. Further, we also discuss the mechanisms influenza virus utilizes, especially the role of viral non-structure proteins NS1, PB1-F2, and PA-X, to evade the host innate immune responses.

Citing Articles

The Novel H10N3 Avian Influenza Virus Triggers Lethal Cytokine Storm by Activating Multiple Forms of Programmed Cell Death in Mammalian Lungs.

Wang X, Wang X, Hao X, Gao R, Lu X, Yang W Int J Mol Sci. 2025; 26(5).

PMID: 40076601 PMC: 11899735. DOI: 10.3390/ijms26051977.

Therapeutic Effects of Alkaloids on Influenza: A Systematic Review and Meta-Analysis of Preclinical Studies.

Gong Z, Hu M, Zhao G, Liang N, Zhang H, Li H Int J Mol Sci. 2025; 26(5).

PMID: 40076449 PMC: 11899224. DOI: 10.3390/ijms26051823.

Innate immune sensors and regulators at the blood brain barrier: focus on toll-like receptors and inflammasomes as mediators of neuro-immune crosstalk and inflammation.

Acioglu C, Elkabes S J Neuroinflammation. 2025; 22(1):39.

PMID: 39955600 PMC: 11829548. DOI: 10.1186/s12974-025-03360-3.

Association Between Diabetes Mellitus-Tuberculosis and the Generation of Drug Resistance.

Cornejo-Baez A, Zenteno-Cuevas R, Luna-Herrera J Microorganisms. 2025; 12(12.

PMID: 39770852 PMC: 11728438. DOI: 10.3390/microorganisms12122649.

Functional Involvement of Signal Transducers and Activators of Transcription in the Pathogenesis of Influenza A Virus.

Liu S, Qiu F, Gu R, Xu E Int J Mol Sci. 2025; 25(24.

PMID: 39769350 PMC: 11677356. DOI: 10.3390/ijms252413589.

References

Liu G, Lu Y, Liu Q, Zhou Y . Inhibition of Ongoing Influenza A Virus Replication Reveals Different Mechanisms of RIG-I Activation. J Virol. 2019; 93(6). PMC: 6401434. DOI: 10.1128/JVI.02066-18. View

Levene R, Gaglia M . Host Shutoff in Influenza A Virus: Many Means to an End. Viruses. 2018; 10(9). PMC: 6165434. DOI: 10.3390/v10090475. View

Nemeroff M, Barabino S, Li Y, Keller W, KRUG R . Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs. Mol Cell. 1998; 1(7):991-1000. DOI: 10.1016/s1097-2765(00)80099-4. View

Maelfait J, Roose K, Vereecke L, Mc Guire C, Sze M, Schuijs M . A20 Deficiency in Lung Epithelial Cells Protects against Influenza A Virus Infection. PLoS Pathog. 2016; 12(1):e1005410. PMC: 4731390. DOI: 10.1371/journal.ppat.1005410. View

Zell R, Krumbholz A, Eitner A, Krieg R, Halbhuber K, Wutzler P . Prevalence of PB1-F2 of influenza A viruses. J Gen Virol. 2007; 88(Pt 2):536-546. DOI: 10.1099/vir.0.82378-0. View

Abdoli A, Soleimanjahi H, Kheiri M, Jamali A, Jamaati A . Determining influenza virus shedding at different time points in madin-darby canine kidney cell line. Cell J. 2013; 15(2):130-5. PMC: 3712773. View

Gay N, Gangloff M, ONeill L . What the Myddosome structure tells us about the initiation of innate immunity. Trends Immunol. 2011; 32(3):104-9. DOI: 10.1016/j.it.2010.12.005. View

Matsumoto M, Funami K, Tanabe M, Oshiumi H, Shingai M, Seto Y . Subcellular localization of Toll-like receptor 3 in human dendritic cells. J Immunol. 2003; 171(6):3154-62. DOI: 10.4049/jimmunol.171.6.3154. View

Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H . Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science. 2003; 301(5633):640-3. DOI: 10.1126/science.1087262. View

10.

Zhong Z, Liang S, Sanchez-Lopez E, He F, Shalapour S, Lin X . New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. Nature. 2018; 560(7717):198-203. PMC: 6329306. DOI: 10.1038/s41586-018-0372-z. View

11.

Varga Z, Grant A, Manicassamy B, Palese P . Influenza virus protein PB1-F2 inhibits the induction of type I interferon by binding to MAVS and decreasing mitochondrial membrane potential. J Virol. 2012; 86(16):8359-66. PMC: 3421771. DOI: 10.1128/JVI.01122-12. View

12.

Imai Y, Kuba K, Neely G, Yaghubian-Malhami R, Perkmann T, van Loo G . Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell. 2008; 133(2):235-49. PMC: 7112336. DOI: 10.1016/j.cell.2008.02.043. View

13.

Perez J, Varble A, Sachidanandam R, Zlatev I, Manoharan M, Garcia-Sastre A . Influenza A virus-generated small RNAs regulate the switch from transcription to replication. Proc Natl Acad Sci U S A. 2010; 107(25):11525-30. PMC: 2895093. DOI: 10.1073/pnas.1001984107. View

14.

Weber M, Sediri H, Felgenhauer U, Binzen I, Banfer S, Jacob R . Influenza virus adaptation PB2-627K modulates nucleocapsid inhibition by the pathogen sensor RIG-I. Cell Host Microbe. 2015; 17(3):309-319. PMC: 4359673. DOI: 10.1016/j.chom.2015.01.005. View

15.

Lee S, Kok K, Jaume M, Cheung T, Yip T, Lai J . Toll-like receptor 10 is involved in induction of innate immune responses to influenza virus infection. Proc Natl Acad Sci U S A. 2014; 111(10):3793-8. PMC: 3956146. DOI: 10.1073/pnas.1324266111. View

16.

Michallet M, Meylan E, Ermolaeva M, Vazquez J, Rebsamen M, Curran J . TRADD protein is an essential component of the RIG-like helicase antiviral pathway. Immunity. 2008; 28(5):651-61. DOI: 10.1016/j.immuni.2008.03.013. View

17.

Lin L, Liu Q, Berube N, Detmer S, Zhou Y . 5'-Triphosphate-short interfering RNA: potent inhibition of influenza A virus infection by gene silencing and RIG-I activation. J Virol. 2012; 86(19):10359-69. PMC: 3457308. DOI: 10.1128/JVI.00665-12. View

18.

Hayashi T, MacDonald L, Takimoto T . Influenza A Virus Protein PA-X Contributes to Viral Growth and Suppression of the Host Antiviral and Immune Responses. J Virol. 2015; 89(12):6442-52. PMC: 4474289. DOI: 10.1128/JVI.00319-15. View

19.

Gack M, Shin Y, Joo C, Urano T, Liang C, Sun L . TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature. 2007; 446(7138):916-920. DOI: 10.1038/nature05732. View

20.

Cros J, Garcia-Sastre A, Palese P . An unconventional NLS is critical for the nuclear import of the influenza A virus nucleoprotein and ribonucleoprotein. Traffic. 2005; 6(3):205-13. DOI: 10.1111/j.1600-0854.2005.00263.x. View